PROFILE OF THE LETHALITY COEFFICIENT FROM HIV/AIDS IN THE STATE OF PARAÍBA IN 2023
Article Sidebar
Main Article Content
Abstract
The present study aims to describe the mortality rate due to AIDS/HIV in the state of Paraíba in the year 2023. It is a descriptive, exploratory, cross-sectional study using a quantitative approach. The data researched in the Information Technology Department of the Unified Health System regarding the number of cases of deaths by ICD B20 and B24, resulted in 2868 cases of HIV by the year 2023 and 637 cases of deaths from the basic HIV/AIDS tail. . Of these, the general lethality coefficient resulted in 22.23, of the numbers presented, the male population presented a greater number of registered cases as well as a higher lethality coefficient of 0.63, while in the female population it was 0.36, such results may be associated with lower adherence of the male population to seeking health services, as well as adhering to treatment. In addition to the point estimates, estimates of 95% confidence intervals for AIDS lethality were added. Statistics based on official SUS data, such as the lethality coefficient, are essential for evaluating and implementing public policies aimed at controlling AIDS and reducing the incidence and deaths from the disease.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c). Conjuncture Bulletin (BOCA)
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
AFRASHTEH, S. et al. “Factors associated with late antiretroviral therapy initiation among people living with HIV in southern Iran: a historical cohort study”. Frontiers in Public Health, vol. 10, 2022.
BOGDANIĆ, N. et al. “Timeliness of antiretroviral therapy initiation in the era before universal treatment”. Scientific Reports, vol. 1, n. 11, 2021.
BRASIL. Boletim Epidemiológico do Estado da Paraíba. Brasília: SINAN, 2023. Disponível em: . Acesso em: 26/10/2024.
BRASIL. Estatísticas Globais sobre HIV 2021. Brasília: Ministério da Saúde, 2023. Disponível em: . Acesso em: 26/10/2024.
CARMO, R. A. et al. “Subnotificação de óbitos por AIDS no Brasil: Linkage dos registros hospitalares com dados de declaração de óbito”. Ciência e Saúde Coletiva, vol. 4, n. 26, 2021.
CUNHA, A. P.; CRUZ, M. M.; PEDROZO, M. “Análise da tendência da mortalidade por HIV/AIDS segundo características sociodemográficas no Brasil, 2000 a 2018”. Ciência e Saúde Coletiva, vol. 27 2022.
FARIAS, G. M. et al. “Prevalência das internações por AIDS em um hospital de referência no estado da Paraíba”. Boletim de Conjuntura (BOCA), vol. 20, n. 58, 2024.
FREDERICKSEN, R. J. et al. “Impact and correlates of sub-optimal social support among patients in HIV care”. AIDS Care, vol. 33, 2021.
GAMA, W. M. et al. “Immunologic biomarkers, morbidity and mortality among HIV patients hospitalised in a Tertiary Care Hospital in the Brazilian Amazon”. BMC Infectious Diseases, vol. 21, n 2, 2021.
GARCIA E. C. et al. “Representações sociais de adolescentes sobre a transmissão do HIV/AIDS nas relações sexuais: vulnerabilidades e riscos”. Escola Anna Nery, n. 26, 2022.
LI, B. et al. “The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study”. BMC Public Health, vol. 24, n. 1, 2024.
MACHADO, C. A. L. et al. “Epidemiological profile and lethality of visceral leishmaniasis/human immunodeficiency virus co-infection in an endemic area in Northeast Brazil”. Revista da Sociedade Brasileira de Medicina Tropical, n. 54, 2021.
MALTA, D. C. et al. “Mortalidade de adolescentes e adultos jovens brasileiros entre 1990 e 2019: uma análise do estudo Carga Global de Doença”. Ciência e Saúde Coletiva, vol. 26, 2021.
MINISTÉRIO DA SAÚDE. Boletim Epidemiológico: HIV/Aids. Brasília: Ministério da Saúde, 2024. Disponível em: . Acesso em: 26/10/2024.
MINISTÉRIO DA SAÚDE. Protocolo clínico e diretrizes terapêuticas para profilaxia pós-exposição (PEP) de risco à infecção pelo HIV, IST e hepatites virais. Brasília: Ministério da Saúde, 2023. Disponível em: . Acesso em: 23/03/1014.
MONAGHAN, T. F. et al. “Foundational Statistical Principles in Medical Research: A Tutorial on Odds Ratios, Relative Risk, Absolute Risk, and Number Needed to Treat”. International Journal of Environmental Research and Public Health, vol. 18, n. 11, 2021.
MONTANA, J. F. et al. “The HIV epidemic in Colombia: spatial and temporal trends analysis”. BMC Public Health, vol. 21, n.1, 2021.
NIK, J. A. A. et al. “Leong Bin Abdullah MFI: posttraumatic growth and its association with unmet supportive care needs and fear of cancer progression among head and neck cancer patients”. PLoS One, vol. 3, n. 17, 2022.
OLIVEIRA, E. V.; MARTINS, W. “Principais fatores do crescimento de HIV na terceira idade”. Boletim de Conjuntura (BOCA), vol. 6, n. 17, 2021.
PEARSON, C. A, et al. “Internalized HIV Stigma predicts suboptimal Retention in Care among people living with HIV in the United States”. AIDS Patient Care STDS, vol. 5, n 35, 2021.
RIVERA-PICÓN, C. et al. “Differences in Resilience, Psychological Well-Being and coping strategies between HIV patients and diabetics”. Healthc, vol. 2, n .10, 2022.
VIEIRA, G. N. et al. “!O HIV/AIDS entre os jovens no Brasil: revisão integrativa da literatura”. Health Bios, vol. 1, n. 2, 2021.
WANG, X. et al. “Fear of progression, anxiety, and Depression in patients with Advanced Melanoma in the COVID-19 and Post-COVID-19 era”. Front Psychiatry, vol. 13, 2022.
WHO - World Health Organization. World Aids Day. Genebra: WHO; 2021 Disponível em: . Acesso em: 23/04/2024.
YIMER, A. et al. “Prevalence of misconception about HIV/AIDS transmission and associated factors among reproductive age women in Ethiopia: a nationwide study”. BMC Infectious Diseases, vol. 24, n. 1, 2024.